Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Uniphos Enterprises Ltd (UNIENTER)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500429 NSE: UNIENTER Trading | Small Cap | Uniphos Enterprises Share Price
₹98.70 -0.20 (-0.20%)
As on 24-Jul'26 16:59
Uniphos Enterprises Ltd (UNIENTER)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500429 NSE: UNIENTER Trading | Small Cap | Uniphos Enterprises Share Price
₹98.70 -0.20 (-0.20%)
As on 24-Jul'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹686 Cr.
Current Price
₹98.7
52-Week Low / High
₹87 / 164
TTM EPS
₹3
TTM Sales
₹32 Cr.
Book Value per Share
₹331
P/E Ratio
33.14
Higher than its 5-year historical median
Industry PE
38.1
Price to Book (P/B)
0.30
Lower than its 5-year historical median
Price to Sales (P/S)
21.45
Higher than its 5-year historical median
EV/EBITDA
31.18
Higher than its 5-year historical median
Dividend Yield
3.55%
Profitability Efficiency
Return on Equity (ROE)
0.85%
Underperforms industry median
Return on Capital Employed (ROCE)
0.85%
Underperforms industry median
Return on Assets (ROA)
0.76%
Operating Profit Margin
-11.6%
Net Profit Margin
64.72%
Gross Profit Margin
67.2%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-71.3%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
7296.43%
Asset Quality
Promoter Holding
73.79%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹2,288 Cr.
Equity
₹13.9 Cr.
Face Value
₹2
All Time Low / High
₹6.24 / 1783.47
Check Before You Invest
Quality
Not GoodValuation
FairCheck Valuation charts
Price Trend
Weak
Is Uniphos Enterprises Ltd a good quality company?
Uniphos Enterprises Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Uniphos Enterprises Ltd performance compare with that of its Peers?
Revenue growth of Uniphos Enterprises Ltd vs industry peers?
Uniphos Enterprises Ltd revenue CAGR is 107.59%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Uniphos Enterprises Ltd?
Promoters hold 73.79% of the Uniphos Enterprises Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Uniphos Enterprises Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 7% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Uniphos Enterprises Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 1.1% | 0.9% | 0.9% | 1% | 1.2% | 1.9% | 1.4% | 1.6% | 0.1% | 0.9% | - |
| Value Creation Index ⓘ | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -1.0 | -0.9 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0.2 | 0.8 | 1.2 | 1.5 | 50.7 | 112 | 32 | 32 |
| Sales YoY Gr. | - | NA | NA | NA | 260.9% | 47% | 20.5% | 3,345.6% | 120.2% | -71.3% | - |
| Adj EPS ⓘ | 1.6 | 2.5 | 2.9 | 3 | 3.5 | 7.8 | 5.5 | 5.4 | 0.1 | 2.9 | 3 |
| YoY Gr. | - | 56.8% | 15% | 1.4% | 16.9% | 124.9% | -29.1% | -1.5% | -97.4% | 1992.9% | - |
| BVPS (₹) ⓘ | 276.3 | 279.7 | 367 | 197.4 | 369.5 | 436.5 | 410.2 | 277.6 | 373.4 | 331 | 331 |
| Adj Net Profit ⓘ | 11.3 | 17.7 | 20.3 | 20.6 | 24.1 | 54.1 | 38.4 | 37.8 | 1 | 20.4 | 21 |
| Cash Flow from Ops. ⓘ | -1.8 | -3.4 | -3.2 | -2.1 | -4.6 | 0.5 | -1.5 | -3.5 | -2.7 | -3.4 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 107.6% | 179.2% | -71.3% | ||||
| Adj EPS ⓘ | 6.8% | -3.3% | -19% | 1992.9% | ||||
| BVPSⓘ | 2% | -2.2% | -6.9% | -11.4% | ||||
| Share Price | 6.8% | -6.4% | -15.2% | -38.1% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1 | 0.9 | 0.9 | 1 | 1.1 | 1.8 | 1.2 | 1.5 | 0 | 0.8 | 0.9 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | -1000.4 | -368 | -255.9 | -194.5 | -6.1 | -2.5 | -11.6 | -5.2 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 9062.8 | 2887.8 | 4425.8 | 2608.9 | 74.7 | 0.9 | 63.8 | 64.8 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Cap Days ⓘ | 0 | 0 | 0 | 63,940 | 18,027 | 12,056 | 7,709 | 166 | 83 | 437 | 41 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | -116 | -59 | -44 | -61 | -6 | -3 | 1 | 16 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 32 |
| Operating Expenses ⓘ + | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 54 | 115 | 36 |
| Operating Profit ⓘ | -2 | -2 | -3 | -3 | -3 | -3 | -3 | -3 | -4 | -4 |
| Operating Profit Margin (%) | - | - | - | -1,302.8% | -368.0% | -255.0% | -194.0% | -6.1% | -3.4% | -11.6% |
| Other Income ⓘ + | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 25 |
| Interest ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Depreciation ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax ⓘ | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | 21 |
| Tax ⓘ | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | -0 | 0 |
| Profit After Tax | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 21 |
| PAT Margin (%) | - | - | - | 8,851.2% | 2,936.4% | 4,469.1% | 2,665.0% | 76.2% | 0.3% | 64.7% |
| Adjusted EPS (₹) | 1.6 | 2.5 | 3.0 | 2.9 | 3.5 | 7.9 | 5.6 | 5.6 | 0.0 | 3.0 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 96.70% | 72% | 115.20% | 102.70% | 1,250% | 117.50% |
Valuation of Uniphos Enterprises - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 2,067 | 2,090 | 2,698 | 1,518 | 2,715 | 3,181 | 2,998 | 2,075 | 2,742 | 2,447 | |
| Debt + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 27 | |
| Others Liabilities ⓘ | 0 | 0 | 0 | 0 | 57 | 121 | 97 | -21 | 99 | 145 | |
| Total Liabilities ⓘ | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,056 | 2,842 | 2,619 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Investments ⓘ | 1,856 | 2,046 | 2,658 | 1,435 | 2,550 | 3,080 | 2,856 | 1,803 | 2,616 | 2,372 | |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | |
| Cash Equivalents | 1 | 6 | 1 | 43 | 4 | 7 | 32 | 48 | 16 | 16 | |
| Others Assets ⓘ | 35 | 38 | 39 | 41 | 217 | 214 | 207 | 206 | 210 | 204 | |
| Total Assets ⓘ | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,056 | 2,842 | 2,619 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | -2 | -3 | -3 | -2 | -5 | 1 | -1 | -3 | -3 | -3 |
| Cash Flow From Investing Activity ⓘ + | -0 | 9 | -2 | 44 | -34 | 20 | 41 | 50 | 53 | 10 |
| Cash Flow From Financing Activity ⓘ + | 0 | 0 | 0 | 0 | 0 | -24 | -39 | -45 | -41 | -3 |
| Net Cash Flow ⓘ | -2 | 5 | -5 | 42 | -38 | -3 | -0 | 1 | 9 | 3 |
Financial Ratio
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 1.09 | 0.91 | 0.92 | 1.02 | 1.24 | 1.95 | 1.33 | 1.61 | 0.01 | 0.85 |
| ROCE (%) | 1.09 | 0.93 | 0.94 | 1.04 | 1.19 | 1.92 | 1.35 | 1.63 | 0.07 | 0.85 |
| Asset Turnover Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.05 | 0.01 |
| PAT to CFO Conversion(x) | -0.18 | -0.17 | -0.14 | -0.1 | -0.21 | 0.02 | -0.03 | -0.08 | N/A | -0.14 |
| Working Capital Days | ||||||||||
| Receivable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.50 | 0 | 298.20 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 0 | 0 | 0 | 684.20 | 189.20 | 90.50 | 143.30 | 8 | 3.70 | 159.20 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Uniphos Enterprises Ltd FAQs
The current trading price of Uniphos Enterprises on 24-Jul-2026 16:59 is ₹98.70.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jul-2026 the market cap of Uniphos Enterprises stood at ₹686.4 Cr
The latest P/E ratio of Uniphos Enterprises as of 23-Jul-2026 is 33.14.
The latest P/B ratio of Uniphos Enterprises as of 23-Jul-2026 is 0.30.
The 52-week high of Uniphos Enterprises is ₹164.4 and the 52-week low is ₹87.35.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Uniphos Enterprises is ₹32.00 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Uniphos Enterprises Ltd is a below average quality company.
The key valuation ratios of Uniphos Enterprises Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Uniphos Enterprises Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Uniphos Enterprises Ltd
Uniphos Enterprises was incorporated with the purpose of carrying out business pertaining to trading of agro products, chemicals and non-chemicals.
Uniphos Enterprise is associate company of the United Phosphorus Group. Presently, it is in the business of trading of chemicals, import and export of engineering goods, agricultural products and various other items.
The equity shares of the company are listed on the Bombay Stock Exchange and National Stock Exchange of India.
The company’s registered office is located at 11, GIDC, Vapi, Valsad District, Gujarat 396 195.
You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
